Preventive care is now a $99-to-$20,000 price ladder — demand compounds, but economics bifurcate
Asked:
“Help me analyze financial trends in concierge medicine (also has different names like longevity, functional, precision, preventative)”
This report reads 101 curated evidence rows — live provider pricing pages, the 2026 DPC physician survey, MGMA adoption counts for 2018–2023, funding announcements through July 2026, and one publisher market forecast — as of September 1, 2026. Prices are in U.S. dollars unless flagged; recurring memberships and one-off scans or visits are kept apart throughout.
Five business models, not one market
Market-size estimates are not interchangeable across publishers — each defines the category differently. Compare within a rung, not across the ladder.
Concierge / DPCPhysician retainer or flat monthly membership (MDVIP, DPC practices)
Preventive lab membershipsLow-cost recurring biomarker testing (Function Health)
Functional medicineRoot-cause consults, often per visit (Parsley Health)
Imaging-led screeningWhole-body MRI, per scan or membership (Prenuvo, Neko)
Premium longevityExecutive-grade diagnostics and care teams (Fountain Life)
The price ladder — what a year of “prevention” costs, on a log scale
recurring membership (annual)transactional (per scan / per visit)
Log-scale annual or per-unit price in USD. Bars show the sampled range on live provider pages; a single tick is one published price. MDVIP is a range across 18 sampled annual physician listings, not a network average. Prenuvo per-scan rows come from Australian pages — currency and geography are not directly U.S.-comparable.
Adoption nearly doubled, 2018→2023
U.S. concierge/DPC counts, MGMA summary. Sites +83.1%, clinicians +78.4%; corporate-affiliated practices grew 576%.
DPC monthly price by region
Average membership, USD per member per month, 2026 DPC Alliance physician survey (3,600+ practices).
Capital concentrates behind diagnostics platforms — and punishes capex-heavy clinics
capital raisedraised, then shut down
Announced financing events, USD millions. Forward's $400M is the cumulative headline figure at its 2024 shutdown.
Risk / opportunity matrix for diligence
Opportunity — revenue quality
- Recurring memberships at every rung: $99/yr access to ~$20,000/yr longevity programs — prevention is a price architecture, not a luxury niche
- DPC national average $98.64/mo with sector growth above 19%
- Diagnostics gross margins and cross-sell (labs → imaging → care) attract growth capital
Risk — unit economics
- 68.4% of DPC panels are not yet full: customer acquisition and payback remain unproven at many sites
- Forward shut down in 2024 after ~$400M raised — clinic capex plus automation does not guarantee durable economics
- Publisher market sizes ($23.57B → $49B) are directional, not audited, and definitions differ
What to diligence next
- Panel fill rate, CAC and payback by cohort; churn/retention on lab and imaging memberships
- Clinician leverage (members per physician) and diagnostics gross margin by modality
- Attach rates from screening to ongoing care; employer and insurance channel traction
Data caveats
- Consumer prices are from live provider pages and can change; promotional or geo-specific offers appear in the rows
- MDVIP figures are a sampled range from physician pages, not a network-wide average
- Some Prenuvo pages are Australian; currency scope flagged, not silently pooled
More than 3,600 DPC practices report a $98.64 national average monthly price and >19% growth — yet 68.4% of panels are not full.
blog.hint.comU.S. concierge/DPC sites grew from 1,658 to 3,036 (+83.1%) and clinicians from 3,935 to 7,021 (+78.4%) over 2018–2023.
mgma.comNeko Health's $700M Series C (July 2026) and Function Health's $450M growth round after a $298M Series B show capital favoring scalable diagnostics over clinic buildouts.
nekohealth.com ·
fiercehealthcare.comForward shut down in 2024 after a headline ~$400M raised — the sector's clearest warning on capex-heavy automated clinics.
fiercehealthcare.comA publisher forecast sizes global concierge medicine at $23.57B (2025) growing to $49B by 2032 (11% CAGR) — directional only, not an audited total.
globenewswire.com
The evidence, row by row
| Model / entity | Offer | Price / value | Basis | Note | Source |
|---|
Curated evidence set: 101 rows spanning consumer pricing pages (76 rows), the 2026 DPC Alliance physician survey (9), MGMA 2018–2023 adoption counts (7), capital events (6), and one publisher market forecast (3), assembled as of 2026-09-01. Prices are USD unless flagged as Australian pages; recurring fees and per-scan/per-visit prices are kept distinct. MDVIP quarterly and semi-annual installments were excluded from the ladder; only the 18 sampled annual listings are shown, as a range. Individual duplicate price rows and unattributed entities were folded for space.